Latent Structure of Multi-level Assessments and Predictors of Outcomes in Psychiatric Disorders
NCT02450240 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1271
Last updated 2020-07-07
Summary
In this study the investigators will seek to improve our understanding of how positive and negative valence systems, cognition, and arousal/interoception are inter-related in disorders of mood, substance use, and eating behavior. The investigators will recruit 1000 individuals and use a wide range of assessment tools, neuroimaging measures, blood and microbiome collections and behavioral tasks to complete the baseline and follow-up study visits. Upon completion, the investigators aim to have robust and reliable dimensional measures that quantify these systems and a set of assessments that should be recommended as a clinical tool to enhance outcome prediction for the clinician and assist in determining who will likely benefit from what type of intervention.
Conditions
- Depression
- Anxiety
- Eating Disorders
- Drug Use Disorders
Interventions
- BEHAVIORAL
-
standardized diagnostic assessment
- BEHAVIORAL
-
self-report questionnaires
- BEHAVIORAL
-
behavioral tasks
- OTHER
-
physiological measurements
- OTHER
-
structural and functional magnetic resonance imaging and EEG
- OTHER
-
biomarker and microbiome assessments
- OTHER
-
blood to derive induced pluripotent stem cells
- OTHER
-
genetic and epigenetic assessments
Sponsors & Collaborators
-
University of Oklahoma
collaborator OTHER -
Rutgers University
collaborator OTHER -
University of California, San Diego
collaborator OTHER -
Laureate Institute for Brain Research, Inc.
lead OTHER
Principal Investigators
-
Martin P Paulus, M.D. · Laureate Institute for Brain Research
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2020-06-30
- Completion
- 2020-06-30
Countries
- United States
Study Locations
More Related Trials
-
Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With Schizophrenia
NCT02202226 ·Status: COMPLETED ·Phase: PHASE1
-
Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia
NCT01036568 ·Status: COMPLETED
-
Neurophysiological Studies in Schizophrenia and Psychiatric Disorders
NCT01384604 ·Status: COMPLETED
-
Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
NCT04218981 ·Status: COMPLETED ·Phase: NA
-
Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia
NCT00207064 ·Status: COMPLETED ·Phase: NA
-
Psychiatric Multi-omics and Neuroimaging Project
NCT06580860 ·Status: RECRUITING
-
Minnesota Community-Based Cognitive Training in Early Psychosis
NCT03079024 ·Status: COMPLETED ·Phase: NA
-
Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study
NCT03442101 ·Status: ACTIVE_NOT_RECRUITING
-
A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone
NCT01979679 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanisms of Response to Therapeutic Intervention in Clinical High Risk (CHR) for Psychosis
NCT06542640 ·Status: RECRUITING ·Phase: NA
-
Studies of Frontal Lobe Brain Functioning in Schizophrenia
NCT00001258 ·Status: COMPLETED
-
Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States
NCT01425671 ·Status: COMPLETED
-
Remote State Representation in Early Psychosis
NCT05538832 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
State Representation in Early Psychosis - Project 4
NCT05664594 ·Status: COMPLETED ·Phase: NA
-
EEG and Behavioral Correlates of Temporal Prediction in the Tactile Modality in Schizophrenia
NCT05296720 ·Status: RECRUITING ·Phase: NA
-
Serotonin 1A Agonists and Cognition in Schizophrenia
NCT00178971 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis
NCT02566057 ·Status: COMPLETED ·Phase: NA
-
Tracking Outcomes in Psychosis
NCT02882204 ·Status: UNKNOWN
-
A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Males
NCT02935725 ·Status: COMPLETED ·Phase: PHASE1
-
SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia
NCT00364429 ·Status: TERMINATED ·Phase: PHASE1
-
Biomarkers in Schizophrenia
NCT00817336 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate The Effects of RO5545965 in Participants With Negative Symptoms of Schizophrenia Treated With Antipsychotics
NCT02824055 ·Status: COMPLETED ·Phase: PHASE1
-
State Representation in Early Psychosis
NCT05273164 ·Status: COMPLETED
-
Characterization of High-Level Cognitive Impairments in Patients With Neuropsychiatric Disorders
NCT07295652 ·Status: RECRUITING ·Phase: NA
-
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
NCT00178932 ·Status: COMPLETED ·Phase: NA